|
| << previous |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 24 of 24 found articles
| Title: |
VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma |
| Author: |
Tewari, K.S. Monk, B.J. Vergote, I. Miller, A. de Melo, A.C. Kim, H.S. Kim, Y.M. Lisyanskaya, A. Samouëlian, V. Lorusso, D. Damian, F. Chang, C-L. Gotovkin, E.A. Takahashi, S. Ramone, D. Pikiel, J. Li, J. Mathias, M. Fury, M.G. Oaknin, A. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 32 () nr. 7 pages 940-941 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
Published by Elsevier B.V. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 24 of 24 found articles
| << previous |